Nippon Soda (4041) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
14 May, 2026Executive summary
Net sales for FY ended March 2026 were ¥152.09B, down 2.0% year-over-year; operating profit fell 6.8% to ¥14.97B.
Ordinary profit rose 17.7% to ¥22.99B, and profit attributable to owners increased 21.7% to ¥18.27B, driven by higher equity-method profits and foreign exchange gains.
Comprehensive income surged to ¥31.26B, up 488.7% from the previous year.
Sales in Chemical Materials, Agri Business, and Eco Solutions were steady, but Engineering segment declined due to reduced plant construction work.
Financial highlights
Earnings per share increased 23.5% year-over-year to ¥336.54, reflecting the 2-for-1 share split.
Share of profit from equity-method affiliates more than doubled, mainly from IHARABRAS, reaching ¥6.06B.
Extraordinary gains rose to ¥5.46B, mainly from investment securities sales; extraordinary losses increased to ¥3.72B due to structural reforms and plant closures.
Free cash flow improved to ¥10.79B, up ¥5.72B year-over-year.
Return on equity improved to 9.3% from 8.0% year-over-year.
Outlook and guidance
FY ending March 2027 forecasts net sales of ¥152.20B (flat), operating profit of ¥14.20B (down 5.1%), and profit attributable to owners of ¥15.80B (down 13.5%).
Basic EPS projected at ¥294.77; annual dividend forecast is ¥160 per share.
Inventory valuation gains in Agri Business expected to decrease; equity-method profit to decline due to reversal of prior FX gains.
Assumed exchange rates: 1 USD = ¥150, 1 EUR = ¥175.
Latest events from Nippon Soda
- Targets ¥20B+ net income by FY2030/3, driven by innovation, global growth, and sustainability.4041
Investor presentation14 May 2026 - Operating and ordinary profits rose despite lower sales, driven by Agri Business and equity gains.4041
Q3 202610 Mar 2026 - Sales and profits fell on Agri Business weakness, but full-year growth and a share split are forecast.4041
Q1 202510 Mar 2026 - Operating profit rose 9.6% YoY despite lower sales and a revised full-year outlook.4041
Q2 202510 Mar 2026 - Operating profit rose 15.8% but net and comprehensive income fell; FY2026 outlook is cautious.4041
Q4 202510 Mar 2026 - Profit rose on Chemical Materials and Engineering strength, but comprehensive income dropped sharply.4041
Q3 202510 Mar 2026 - Flat sales and profit, but strong profit growth and a positive FY2026 outlook.4041
Q2 202610 Mar 2026 - Sales and operating profit rose, but net income dropped 25.9% on forex losses.4041
Q1 202610 Mar 2026